Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15077033rdf:typepubmed:Citationlld:pubmed
pubmed-article:15077033lifeskim:mentionsumls-concept:C0010825lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0376387lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0018823lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0017649lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0017066lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:15077033lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:15077033pubmed:issue6lld:pubmed
pubmed-article:15077033pubmed:dateCreated2004-4-12lld:pubmed
pubmed-article:15077033pubmed:abstractTextSeronegative heart transplant recipients who receive an allograft from seropositive donors have a higher risk of developing cytomegalovirus (CMV) disease and cardiac allograft vasculopathy (CAV) and dysfunction. Neither CMV-specific hyperimmune globulin nor ganciclovir as sole CMV prophylaxis is sufficient to prevent CMV disease in high-risk patients. We retrospectively evaluated the efficacy of CMV-hyperimmune globulin with and without ganciclovir in 207 D+/R- heart transplant recipients.lld:pubmed
pubmed-article:15077033pubmed:languageenglld:pubmed
pubmed-article:15077033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:citationSubsetIMlld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15077033pubmed:statusMEDLINElld:pubmed
pubmed-article:15077033pubmed:monthMarlld:pubmed
pubmed-article:15077033pubmed:issn0041-1337lld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:GrimmMichaelMlld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:WolnerErnstElld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:KocherAlfredAlld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:AnkersmitJanJlld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:LauferGünther...lld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:EhrlichMarekMlld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:ZuckermannAnd...lld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:DunklerDaniel...lld:pubmed
pubmed-article:15077033pubmed:authorpubmed-author:BonarosNikola...lld:pubmed
pubmed-article:15077033pubmed:issnTypePrintlld:pubmed
pubmed-article:15077033pubmed:day27lld:pubmed
pubmed-article:15077033pubmed:volume77lld:pubmed
pubmed-article:15077033pubmed:ownerNLMlld:pubmed
pubmed-article:15077033pubmed:authorsCompleteYlld:pubmed
pubmed-article:15077033pubmed:pagination890-7lld:pubmed
pubmed-article:15077033pubmed:dateRevised2009-10-8lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:meshHeadingpubmed-meshheading:15077033...lld:pubmed
pubmed-article:15077033pubmed:year2004lld:pubmed
pubmed-article:15077033pubmed:articleTitleComparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.lld:pubmed
pubmed-article:15077033pubmed:affiliationDepartment of Cardiac Surgery, University of Innsbruck, Innsbruck Austria. nikolaos.bonaros@uibk.ac.atlld:pubmed
pubmed-article:15077033pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15077033pubmed:publicationTypeComparative Studylld:pubmed